Nine drugs and vaccines created through biotechnology have reached the U.S. market and 81 others are in the final stages of development, according to an industry-sponsored survey released Tuesday.A strong business commitment to biotechnology is benefiting the public by creating products that can unclog heart vessels, ease transplants and treat diseases such as diabetes, leukemia and hemophilia, Washington-based Pharmaceutical Manufacturers Association said.